Biocon Biologics gets MHRA approval for YESAFILI, biosimilar Aflibercept
In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.